Factors that regulate naturally occurring T regulatory cell-mediated suppression.

[1]  T. Chatila.  Role of regulatory T cells in human diseases. , 2005, The Journal of allergy and clinical immunology.

[2]  Cezmi A Akdis,et al.  T regulatory cells in allergy: novel concepts in the pathogenesis, prevention, and treatment of allergic diseases. , 2005, The Journal of allergy and clinical immunology.

[3]  S. Jacobson,et al.  Virus-induced dysfunction of CD4+CD25+ T cells in patients with HTLV-I-associated neuroimmunological disease. , 2005, The Journal of clinical investigation.

[4]  A. Scheffold,et al.  Regulation of CD4+CD25+ regulatory T cell activity: it takes (IL‐)two to tango , 2005, European journal of immunology.

[5]  R. Tisch,et al.  Single cell analysis shows decreasing FoxP3 and TGFβ1 coexpressing CD4+CD25+ regulatory T cells during autoimmune diabetes , 2005, The Journal of experimental medicine.

[6]  E. Bettelli,et al.  Foxp3 interacts with nuclear factor of activated T cells and NF-kappa B to repress cytokine gene expression and effector functions of T helper cells. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[7]  M. Colombo,et al.  Triggering of OX40 (CD134) on CD4(+)CD25+ T cells blocks their inhibitory activity: a novel regulatory role for OX40 and its comparison with GITR. , 2005, Blood.

[8]  A. Rudensky,et al.  A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3 , 2005, Nature Immunology.

[9]  H. Cantor,et al.  Regulatory T cells and autoimmune disease , 2005, Immunological reviews.

[10]  H. Boehmer,et al.  Mechanisms of suppression by suppressor T cells , 2005, Nature Immunology.

[11]  Shimon Sakaguchi,et al.  Homeostatic maintenance of natural Foxp3 + CD25+ CD4+ regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization , 2005, The Journal of experimental medicine.

[12]  David C. Gondek,et al.  Cutting Edge: Contact-Mediated Suppression by CD4+CD25+ Regulatory Cells Involves a Granzyme B-Dependent, Perforin-Independent Mechanism1 , 2005, The Journal of Immunology.

[13]  L. Ou,et al.  Superantigens (SAgs) subvert T regulatory (Treg) cell activity by inducing expression of GITR-L on monocytes , 2005 .

[14]  S. Ziegler,et al.  FOXP3 acts as a rheostat of the immune response , 2005, Immunological reviews.

[15]  A. Saoudi,et al.  Functional defect of regulatory CD4(+)CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis. , 2005, Blood.

[16]  A. Svennerholm,et al.  Mucosal FOXP3-Expressing CD4+ CD25high Regulatory T Cells in Helicobacter pylori-Infected Patients , 2005, Infection and Immunity.

[17]  C. Akdis,et al.  Glucocorticoids upregulate FOXP3 expression and regulatory T cells in asthma. , 2004, The Journal of allergy and clinical immunology.

[18]  S. Sakaguchi,et al.  Control of Foxp3+ CD25+CD4+ regulatory cell activation and function by dendritic cells. , 2004, International immunology.

[19]  R. Medzhitov,et al.  Toll-dependent control mechanisms of CD4 T cell activation. , 2004, Immunity.

[20]  P. Coffer,et al.  Forkhead-box transcription factors and their role in the immune system , 2004, Nature Reviews Immunology.

[21]  T. Nomura,et al.  Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells. , 2004, International immunology.

[22]  K. Mills,et al.  Regulatory T cells: friend or foe in immunity to infection? , 2004, Nature Reviews Immunology.

[23]  S. Sakaguchi,et al.  CD4+ Tregs and immune control. , 2004, The Journal of clinical investigation.

[24]  Steven M. Chan,et al.  Murine CD4+CD25+ Regulatory T Cells Fail to Undergo Chromatin Remodeling Across the Proximal Promoter Region of the IL-2 Gene1 , 2004, The Journal of Immunology.

[25]  Ethan M. Shevach,et al.  Engagement of Glucocorticoid-Induced TNFR Family-Related Receptor on Effector T Cells by its Ligand Mediates Resistance to Suppression by CD4+CD25+ T Cells , 2004, The Journal of Immunology.

[26]  D. Munn,et al.  Ido expression by dendritic cells: tolerance and tryptophan catabolism , 2004, Nature Reviews Immunology.

[27]  T. Ley,et al.  Human T regulatory cells can use the perforin pathway to cause autologous target cell death. , 2004, Immunity.

[28]  S. Rutz,et al.  Interleukin‐2 is essential for CD4+CD25+ regulatory T cell function , 2004, European journal of immunology.

[29]  S. Ziegler,et al.  CD25+CD4+ Regulatory T Cells from the Peripheral Blood of Asymptomatic HIV-infected Individuals Regulate CD4+ and CD8+ HIV-specific T Cell Immune Responses In Vitro and Are Associated with Favorable Clinical Markers of Disease Status , 2004, The Journal of experimental medicine.

[30]  W. Shearer,et al.  Advances in asthma, allergy and immunology series 2004: basic and clinical immunology. , 2004, The Journal of allergy and clinical immunology.

[31]  D. Robinson,et al.  Fluticasone propionate increases CD4CD25 T regulatory cell suppression of allergen-stimulated CD4CD25 T cells by an IL-10-dependent mechanism. , 2004, The Journal of allergy and clinical immunology.

[32]  Linrong Lu,et al.  Engagement of B7 on effector T cells by regulatory T cells prevents autoimmune disease. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[33]  K. Karube,et al.  Expression of FoxP3, a key molecule in CD4+CD25+ regulatory T cells, in adult T‐cell leukaemia/lymphoma cells , 2004, British journal of haematology.

[34]  I. Ishikawa,et al.  Costimulation via Glucocorticoid-Induced TNF Receptor in Both Conventional and CD25+ Regulatory CD4+ T Cells1 , 2004, The Journal of Immunology.

[35]  Ethan M. Shevach,et al.  Cutting Edge: IL-2 Is Critically Required for the In Vitro Activation of CD4+CD25+ T Cell Suppressor Function , 2004, The Journal of Immunology.

[36]  S. Durham,et al.  Mechanisms of immunotherapy. , 2004, The Journal of allergy and clinical immunology.

[37]  W. Faubion,et al.  Cutting Edge: The Natural Ligand for Glucocorticoid-Induced TNF Receptor-Related Protein Abrogates Regulatory T Cell Suppression 1 , 2004, The Journal of Immunology.

[38]  H. Lorenz,et al.  Defective Suppressor Function of Human CD4+ CD25+ Regulatory T Cells in Autoimmune Polyglandular Syndrome Type II , 2004, The Journal of experimental medicine.

[39]  M. Farrar,et al.  Distinct IL-2 Receptor Signaling Pattern in CD4+CD25+ Regulatory T Cells1 , 2004, The Journal of Immunology.

[40]  J. Bae,et al.  4‐1BB‐dependent inhibition of immunosuppression by activated CD4+CD25+ T cells , 2004, Journal of leukocyte biology.

[41]  Clare Baecher-Allan,et al.  Loss of Functional Suppression by CD4+CD25+ Regulatory T Cells in Patients with Multiple Sclerosis , 2004, The Journal of experimental medicine.

[42]  H. Nelson.  Advances in upper airway diseases and allergen immunotherapy. , 2004, The Journal of allergy and clinical immunology.

[43]  L. Ou,et al.  T regulatory cells in atopic dermatitis and subversion of their activity by superantigens. , 2004, The Journal of allergy and clinical immunology.

[44]  S. Sakaguchi.  Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. , 2004, Annual review of immunology.

[45]  Sergio Romagnani,et al.  Immunologic influences on allergy and the TH1/TH2 balance. , 2004, The Journal of allergy and clinical immunology.

[46]  D. Sansom,et al.  CD86 and CD80 Differentially Modulate the Suppressive Function of Human Regulatory T Cells1 , 2004, The Journal of Immunology.

[47]  Donald Y M Leung,et al.  Amendment history : Erratum ( April 2004 ) New insights into atopic dermatitis , 2018 .

[48]  E. Shevach,et al.  Activation requirements for the induction of CD4+CD25+ T cell suppressor function , 2004, European journal of immunology.

[49]  K. Sugimoto,et al.  Suppression of HCV‐specific T cells without differential hierarchy demonstrated ex vivo in persistent HCV infection , 2003, Hepatology.

[50]  H. Waldmann,et al.  Mouse glucocorticoid-induced tumor necrosis factor receptor ligand is costimulatory for T cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[51]  U. Grohmann,et al.  Modulation of tryptophan catabolism by regulatory T cells , 2003, Nature Immunology.

[52]  J. Bluestone,et al.  Cutting Edge: CD28 Controls Peripheral Homeostasis of CD4+CD25+ Regulatory T Cells 1 , 2003, The Journal of Immunology.

[53]  D. Umetsu,et al.  Regulatory T cells control the development of allergic disease and asthma. , 2003, The Journal of allergy and clinical immunology.

[54]  R. Steinman,et al.  Direct Expansion of Functional CD25+ CD4+ Regulatory T Cells by Antigen-processing Dendritic Cells , 2003, The Journal of experimental medicine.

[55]  H. Ochs,et al.  Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis , 2003, Current opinion in rheumatology.

[56]  H. Nelson.  Advances in upper airway diseases and allergen immunotherapy. , 2003, The Journal of allergy and clinical immunology.

[57]  A. Kay,et al.  The role of T lymphocytes in the pathogenesis of asthma. , 2003, The Journal of allergy and clinical immunology.

[58]  B. Kwon,et al.  Involvement of tumor necrosis factor receptor superfamily (TNFRSF) members in the pathogenesis of inflammatory diseases , 2003, Experimental & Molecular Medicine.

[59]  I. Caramalho,et al.  Regulatory T Cells Selectively Express Toll-like Receptors and Are Activated by Lipopolysaccharide , 2003, The Journal of experimental medicine.

[60]  A. Frew.  25. Immunotherapy of allergic disease. , 2003, The Journal of allergy and clinical immunology.

[61]  Ruslan Medzhitov,et al.  Toll Pathway-Dependent Blockade of CD4+CD25+ T Cell-Mediated Suppression by Dendritic Cells , 2003, Science.

[62]  T. Nomura,et al.  Control of Regulatory T Cell Development by the Transcription Factor Foxp3 , 2002 .

[63]  P. Blair,et al.  Inhibition of human T cell proliferation by CTLA‐4 utilizes CD80 and requires CD25+ regulatory T cells , 2002, European journal of immunology.

[64]  Ethan M. Shevach,et al.  CD4+CD25+ suppressor T cells: more questions than answers , 2002, Nature Reviews Immunology.

[65]  J. Shimizu,et al.  Stimulation of CD25+CD4+ regulatory T cells through GITR breaks immunological self-tolerance , 2002, Nature Immunology.

[66]  M. Byrne,et al.  CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. , 2002, Immunity.

[67]  S. Ziegler,et al.  Scurfin (FOXP3) Acts as a Repressor of Transcription and Regulates T Cell Activation* , 2001, The Journal of Biological Chemistry.

[68]  E. Shevach,et al.  Control of T‐cell activation by CD4+ CD25+ suppressor T cells , 2001, Immunological reviews.

[69]  A. Bowcock,et al.  JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome. , 2000, The Journal of clinical investigation.

[70]  Guo-liang Yu,et al.  Identification of a Novel Activation-inducible Protein of the Tumor Necrosis Factor Receptor Superfamily and Its Ligand* , 1999, The Journal of Biological Chemistry.

[71]  A. Gurney,et al.  Identification of a new member of the tumor necrosis factor family and its receptor, a human ortholog of mouse GITR , 1999, Current Biology.

[72]  C. Riccardi,et al.  A new member of the tumor necrosis factor/nerve growth factor receptor family inhibits T cell receptor-induced apoptosis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[73]  J. Leyden,et al.  Staphylococcus aureus in the lesions of atopic dermatitis , 1974, The British journal of dermatology.

[74]  J. Bloom,et al.  Update on glucocorticoid action and resistance. , 2003, The Journal of allergy and clinical immunology.

[75]  J. Casanova,et al.  X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy , 2001, Nature Genetics.

[76]  H. Ochs,et al.  The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3 , 2001, Nature Genetics.

[77]  D. Galas,et al.  Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse , 2001, Nature Genetics.